marimastat has been researched along with Hepatocellular Carcinoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bian, H; Chen, ZN; Feng, F; Nan, G; Sun, XX; Wang, B; Wang, Y; Wei, D; Yang, XM; Yuan, L | 1 |
Hori, T; Ido, A; Tsubouchi, H | 1 |
Balabaud, C; Bisson, C; Desmoulière, A; Monvoisin, A; Rosenbaum, J; Si-Tayeb, K | 1 |
1 review(s) available for marimastat and Hepatocellular Carcinoma
Article | Year |
---|---|
[Tumor dormancy therapy for hepatocellular carcinoma].
Topics: Angiostatins; Antibodies; Antineoplastic Agents; Carcinoma, Hepatocellular; Collagen; Endostatins; Endothelial Growth Factors; Hepatocyte Growth Factor; Humans; Hydroxamic Acids; Liver Neoplasms; Lymphokines; Matrix Metalloproteinase Inhibitors; Mitogens; Peptide Fragments; Plasminogen; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
2 other study(ies) available for marimastat and Hepatocellular Carcinoma
Article | Year |
---|---|
A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway.
Topics: Animals; Antibodies; Antibody-Dependent Cell Cytotoxicity; Basigin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; CHO Cells; Cricetulus; Female; Focal Adhesion Kinase 1; Hep G2 Cells; Humans; Hydroxamic Acids; Immunoglobulin G; Immunoglobulin kappa-Chains; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Microfilament Proteins; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Pseudopodia; Recombinant Fusion Proteins; Signal Transduction; Single-Chain Antibodies; Stress Fibers; Vesicular Transport Proteins | 2015 |
Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells.
Topics: Blotting, Northern; Blotting, Western; Carcinoma, Hepatocellular; Collagen; DNA Primers; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Hepatocyte Growth Factor; Humans; Hydroxamic Acids; Laminin; Liver Neoplasms; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Proteoglycans; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Inhibitor of Metalloproteinases; Tumor Cells, Cultured | 2002 |